Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Glycoprotein B Genotyping of Human Cytomegalovirus Strains Isolated from Brazilian Patients with Sickle Cell Disease and Beta-Thalassemia Major

Full text
Author(s):
Slavov, Svetoslav N. [1] ; Kashima, Simone [1, 2] ; Wagatsuma, Virginia M. D. [3] ; Silva-Pinto, Ana Cristina [1] ; Martinez, Edson Z. [4] ; Favarin, Maria do Carmo [1] ; Covas, Dimas T. [1, 5]
Total Authors: 7
Affiliation:
[1] Univ Sao Paulo, Ribeirao Preto Med Sch, Reg Blood Ctr Ribeirao Preto, BR-14051140 Sao Paulo - Brazil
[2] Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, BR-14049 Ribeirao Preto - Brazil
[3] Univ Sao Paulo, Ribeirao Preto Med Sch, Lab Expt Hematol, BR-14051140 Sao Paulo - Brazil
[4] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Social Med, BR-14051140 Sao Paulo - Brazil
[5] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Clin Med, BR-14051140 Sao Paulo - Brazil
Total Affiliations: 5
Document type: Journal article
Source: VIRAL IMMUNOLOGY; v. 28, n. 2, p. 123-129, MAR 1 2015.
Web of Science Citations: 2
Abstract

The role of the human cytomegalovirus (HCMV) infection in individuals with hemoglobinopathies is unclear. Our objective was to examine the molecular and genotypic characteristics of HCMV in patients with sickle cell disease, beta-thalassemia major, and volunteer blood donors by viral load quantitation, glycoprotein B (gB) genotyping, and phylogenetic analysis. The patients with sickle cell disease demonstrated the highest HCMV DNA prevalence (13.8%), followed by the patients with beta-thalassemia major (7.6%), and the blood donors (3%). The infection was characterized by a low mean viral load (3.8x10(3) copies/mL), but infections with higher copy numbers were also observed. Genotype gB2 was detected in the majority of cases (90.9%), followed by genotype gB1 (9.1%). No gB3/gB4 genotype was detected. No statistical significance was observed between HCMV DNAemia/gB genotype and hematological alterations or severity of the disease. The high number of sickle cell disease patients with HCMV DNAemia could be due to their partial immune dysfunction (multiple transfusions, spleen dysfunction, hydroxyurea treatment). The extensive HCMV gB2 prevalence in patients with hemoglobinopathies is probably due to HCMV epidemiologic characteristics in the examined region, and can be important during the clinical management of these patients. (AU)

FAPESP's process: 09/16623-1 - Molecular pathogenesis and clinical consequences of the infections caused by the human parvovirus B19 and Human Cytomegalovirus among patients with hemaglobinopathies and haemophilia
Grantee:Svetoslav Nanev Slavov
Support type: Scholarships in Brazil - Post-Doctorate